| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.3B | $2.2B | $1.9B | $1.8B | $1.9B | $0.4B | $0.4B | $0.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.4B | $0.2B | $0.3B | $0.5B | $1.0B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $37.02 | $20.12 | $22.09 | $39.50 | $59.57 | $9.47 | $8.63 | $7.82 |
| EPS (Diluted) | $36.38 | $19.88 | $21.99 | $39.32 | $59.52 | $9.43 | $8.60 | $7.79 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.6B | $8.9B | $7.6B | $6.9B | $7.1B | $7.5B | $7.4B | $6.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.3B | $0.0B | $0.0B | $0.0B | $0.0B | $0.2B | $0.0B |
| Total Liabilities | $7.1B | $7.1B | $5.9B | $5.3B | $5.2B | $5.2B | $5.1B | $4.2B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.5B | $1.7B | $1.8B | $1.6B | $1.8B | $2.3B | $2.4B | $2.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.1B | $1.2B | $1.2B | $1.1B | $1.0B | $0.8B | $0.7B |
| Investing Cash Flow | $-0.7B | $-1.7B | $-1.4B | $-0.5B | $0.4B | $-0.7B | $-1.0B | $-1.2B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.7B | $1.0B | $0.3B | $-0.8B | $-1.5B | $-0.4B | $0.4B | $0.6B |